CLOV Stock Summary and Trading Ideas (Clover Health Investments Corp. - Class A | NASDAQ:CLOV)

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Clover Health Investments Corp. - Class A trades on the NASDAQ stock market under the symbol CLOV.

As of January 16, 2026, CLOV stock price declined to $2.54 with 8,840,554 million shares trading.

CLOV has a beta of 1.21, meaning it tends to be more sensitive to market movements. CLOV has a correlation of 0.07 to the broad based SPY ETF.

CLOV has a market cap of $1.31 billion. This is considered a Small Cap stock.

Last quarter Clover Health Investments Corp. - Class A reported $497 million in Revenue and -$.05 earnings per share. This beat revenue expectation by $24 million and missed earnings estimates by -$.04.

In the last 3 years, CLOV traded as high as $4.87 and as low as $.61.

The top ETF exchange traded funds that CLOV belongs to (by Net Assets): IWM, VTI, VXF, IWO, SCHA.

CLOV has underperformed the market in the last year with a return of -37.6%, while the SPY ETF gained +18.1%. In the last 3 month period, CLOV fell short of the market, returning -5.9%, while SPY returned +5.0%. However, in the most recent 2 weeks CLOV has outperformed the stock market by returning +5.4%, while SPY returned +1.2%.

CLOV support price is $2.52 and resistance is $2.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLOV shares will trade within this expected range on the day.